Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy (original) (raw)

Beneficial role of intravenous calcitriol on bone mineral density in children with severe secondary hyperparathyroidism

Ali Duzova

International Urology and Nephrology, 2000

View PDFchevron_right

Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis

Ana Paredes

Pediatric Nephrology, 2005

View PDFchevron_right

Intermittent calcitriol therapy in secondary hyperparathyroidism: A comparison between oral and intraperitoneal administration

Jorge Ramirez

Kidney International, 1998

View PDFchevron_right

Treatment of Secondary Hyperparathyroidism in Maintenance Hemodialysis Patients by Intravenous Calcitriol

aquiles jara

Seminars in Dialysis, 1994

View PDFchevron_right

Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patients

Diego Brancaccio

Kidney International, 1992

View PDFchevron_right

Long-term effects of intravenous calcitriol therapy on the control of secondary hyperparathyroidism

Daniele Marcelli

American Journal of Kidney Diseases, 1996

View PDFchevron_right

“High–dose” calcitriol for control of renal osteodystrophy in children on CAPD

Richard Fine

Kidney International, 1987

View PDFchevron_right

Treatment of Secondary Hyperparathyroidism With Low Dose Intermittent Calcitriol in Hemodialysis Patients

Domenico Laganà

ASAIO Journal, 1995

View PDFchevron_right

Effects of calcitriol on parathyroid function and on bone remodelling in secondary hyperparathyroidism

Maria Moyses

Nephrology Dialysis Transplantation, 2003

View PDFchevron_right

The importance of dosing intravenous calcitriol in dialysis patients with severe hyperparathyroidism

Jose Hervás

American Journal of Kidney Diseases, 1995

View PDFchevron_right

Evidence of healing of secondary hyperparathyroidism in chronically hemodialyzed uremic patients treated with long-term intravenous calcitriol

Giuseppe Cannella

Kidney International, 1994

View PDFchevron_right

Comparison between Calcitriol and Calcitriol Plus Low-Dose Cinacalcet for the Treatment of Moderate to Severe Secondary Hyperparathyroidism in Chronic Dialysis Patients

chien-te lee

Nutrients, 2013

View PDFchevron_right

Chronic kidney disease and secondary hyperparathyroidism in children

Alaleh Gheissari

Journal of Parathyroid Disease, 2015

View PDFchevron_right

Usefulness and pharmacokinetics of subcutaneous calcitriol in the treatment of secondary hyperparathyroidism

Jose Vicente Torregrosa

Nephrology Dialysis Transplantation, 1996

View PDFchevron_right

Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1α-hydroxyvitamin D 2) in dialysis patients with secondary hyperparathyroidism: A sequential comparison

Keith Norris

American Journal of Kidney Diseases, 2001

View PDFchevron_right

Parenteral calcitriol for treatment of severe renal osteodystrophy in children with chronic renal insufficiency

Howard Trachtman

The Journal of Pediatrics, 1987

View PDFchevron_right

Changes in bone turnover after parathyroidectomy in dialysis patients: role of calcitriol administration

Francesco Zaraca

Nephrology Dialysis Transplantation, 2000

View PDFchevron_right

Hyperparathyroidism in the hemodialysis population: A survey of 612 patients

Mahmoud Salem

American Journal of Kidney Diseases, 1997

View PDFchevron_right

Secondary hyperparathyroidism in children with symptomatic idiopathic hypercalciuria

Stephanie Ryan

The Journal of Pediatrics, 1983

View PDFchevron_right

Effect of administering calcium carbonate to treat secondary hyperparathyroidism in nondialyzed patients with chronic renal failure

Yusuke Tsukamoto

American Journal of Kidney Diseases, 1995

View PDFchevron_right

The effect of long-term intravenous calcitriol administration on parathyroid function in hemodialysis patients

Arnold Felsenfeld

Journal of the American Society of Nephrology : JASN, 1991

View PDFchevron_right

Effect of percutaneous calcitriol injection therapy on secondary hyperparathyroidism in uraemic patients

Tadao Akizawa

Nephrology Dialysis Transplantation, 2003

View PDFchevron_right

Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial

Lori Wazny, Pharm.D.

The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique, 2008

View PDFchevron_right

Intraperitoneal pulse calcitriol in the treatment of secondary hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis

Samuel Fung

Peritoneal dialysis international: journal of the International Society for Peritoneal Dialysis

View PDFchevron_right